Introduction
Infectious pustular vulvovaginitis (IPV) is a mild infection of the genital tract of cows, first reported in Europe in 1841 as coital exanthema (Greig et al., 1958) . Infectious bovine rhinotracheitis (IBR) is a severe infection of the respiratory tract of cattle, first observed in the USA (Colorado) in 1950 (Miller, 1955) . The first case of IBR in Europe was found in 1960 (Von Gru$ nder et al., 1960) and probably originated from the USA. IPV and IBR are both caused by bovine herpesvirus-1 (BHV-1). Together with the appearance of IBR in Europe, a new virus genotype (BHV-1.1) was detected in Europe (Edwards et al., 1990) , while the older IPV isolates all have a BHV-1.2 genotype. The prototype BHV-1.2 (' IPV-like ') strain K22 and the prototype BHV-1.1 (' IBR-like ') strain Cooper have an estimated sequence identity of 95 % (Mayfield et al., 1983) . Although the epidemiological data strongly suggest that BHV-1.1 (' IBR-like ') strains and BHV-1.2 (' IPV-like ') strains differ in their clinical effects, it is difficult to determine the exact biological differences between the two genotypes. Both genotypes can infect the genital tract and the respiratory tract of cattle. It has been suggested that each genotype is better adapted to either the genital or the respiratory tract, e.g. BHV-1.1 grows better in the respiratory tract than does BHV-1.2 (Edwards et al., 1991) . The molecular mechanisms for such adaptations are still unknown. Here we report on two anti-gC monoclonal antibodies (MAbs 71 and 77) that can differentiate between BHV-1.1 strains and BHV-1.2 strains, suggesting that differences between BHV-1.1 gC and BHV-1.2 gC may play a role in the biological differences between BHV-1.1 and BHV-1.2 strains. Several domains have been identified on gC that may be important for the function(s) of this glycoprotein (Fitzpatrick et al., 1989) , in particular in the role gC plays in 65 ultracentrifuge). The viral DNA was extracted from the virus pellet (van Oirschot et al., 1995) and used either for restriction enzyme analysis or to clone in a prokaryotic vector. To clone the BHV-1.1 gC gene, a 10n7 kbp EcoRI-HindIII fragment that harbours the gC gene (Fitzpatrick et al., 1989) was isolated. This fragment was cloned into the EcoRI and HindIII sites of prokaryotic vector pBR322 using standard procedures (Sambrook et al., 1989) . The resulting plasmid was named p115.
Restriction enzyme analysis. Restriction enzyme analysis for cloning purposes was done according to standard procedures (Sambrook et al., 1989) . To determine the genotype of BHV-1 isolates, 0n5 µg genomic BHV-1 DNA was digested with HindIII and separated on an ethidium bromide-stained, 0n5 % agarose gel.
Construction of recombinant baculoviruses. Recombinant baculoviruses were constructed by using the Bac-to-Bac baculovirus expression system (Life Technologies ; Luckow et al., 1993) . To express either the full-length version or truncated versions of BHV-1.1 gC in baculoviruses, fragments of plasmid p115 were cloned behind the polyhedrin promoter in the transfer vector pFastBac1 by standard cloning procedures (Sambrook et al., 1989) . Recombinant baculovirus genomes were propagated by using DH10Bac cells (Life Technologies) and transfected into Sf21 cells by using lipofectin (Life Technologies).
The recombinant baculoviruses obtained were tested for the expression of gC epitopes by using an IPMA.
Construction of a BHV-1 gC-deletion mutant. For the construction of a BHV-1 gC-deletion mutant, a gC-deletion fragment was first made. To this end, the 2n9 kbp EcoRI-BglII fragment, which covers the complete gC open reading frame (ORF) and its flanking regions, was subcloned into pBluescript SK(j). The resulting clone was digested with NcoI and SplI, treated with Klenow polymerase to fill in the 5h protruding ends and recircularized, causing a 1388 bp deletion of the gC ORF. This deletion starts at the second codon of the gC ORF and causes a frameshift with respect to the last 57 amino acids of the gC ORF. The recircularized gC-deletion plasmid was propagated in Escherichia coli and digested with SacI to separate the 1n3 kbp deletion fragment from the rest of the plasmid. The upstream SacI-NcoI portion is 0n5 kbp long and the downstream SplI-SacI portion is 0n8 kbp long. To generate a BHV-1 gCdeletion mutant, the gC-deletion fragment was co-transfected with wildtype BHV-1 DNA of the Lam strain into EBTr cells by using the method of Graham & van der Eb (1973) . After 48 h, the transfected cells were freeze-thawed to release intracellular virus and a 0n2 µm filtrate of this virus stock was used to infect new monolayers of EBTr cells. To identify gC-deletion mutants, 420 plaques were isolated and grown on EBTr cells in a microtitre plate and subjected to an IPMA with anti-gC MAb 54. Two isolates (7G6 and 8D8) did not react with MAb 54 and were plaquepurified twice and propagated for DNA analysis. Restriction enzyme analysis showed that isolate 8D8 had the predicted 1n4 kbp deletion and no other gross rearrangements in its genome.
Marker rescue. In order to check whether the epitopes of MAbs 71 and 77 are located on the BHV-1.1 glycoprotein gC, marker-rescue experiments were performed by using DNA fragments of plasmid p115 that contained the complete ORF of the gC gene of BHV-1.1 strain Lam or part of it. The BHV-1.1 gC fragments were co-transfected with genomic DNA of BHV-1.2 strain 61.169 into EBTr cells. Two days after the co-transfection, the transfected monolayers were freeze-thawed and collected by centrifugation at 500 g for 15 min. The supernatants obtained were used to infect new monolayers of EBTr cells and, at the time that small plaques started to appear, these monolayers were tested for their reactivity with MAbs 71 and 77 by using the IPMA.
Antibodies. Anti-BHV-1.1 gC MAbs 43 (CVI-BHV-1-979.133.1.1), 54 (CVI-BHV-1-979.35.1.1), 71 (CVI-BHV-1-972.32.1.1) and 77 (CVI-Anti-BHV-1 gC MAbs for IBR/IPV differentiation Anti-BHV-1 gC MAbs for IBR/IPV differentiation BHV-1-978.106.1.1) and anti-BHV-1.1 gB MAb 14 (CVI-BHV-1-999.5.2.2) were obtained after immunization of BALB\c mice with the BHV-1 Lam strain as described by Kramps et al. (1994) .
Immunoblot analysis. Immunoblot analysis was done according to standard procedures (Harlow & Lane, 1988) . In short, EBTr cells were infected with BHV-1 and at complete CPE viruses were isolated and suspended in TE, pH 7n4. The amounts of protein in the preparations were estimated by Coomassie brilliant blue R-250 staining of a test gel. Equal amounts of denatured protein were separated by electrophoresis on an 11 % SDS-PAGE gel and transferred onto a 0n45 µm nitrocellulose membrane (Schleicher & Schuell) by using an LKB Multiphor II semi-dry electrophoresis unit. The membranes were blocked for 2 h with 5 % milk powder in PBS. The nitrocellulose membranes were incubated with either MAb 71 or MAb 77 followed by an incubation with horseradish peroxidase-labelled rabbit anti-mouse IgG (DAKO p260) and stained with AEC (Sigma). To determine the apparent molecular mass, prestained high-range markers from Life Technologies were used. PEPSCAN analysis. A complete set of overlapping dodecapeptides (12 amino acid long peptides) of the predicted BHV-1 gC protein was synthesized on the basis of the nucleotide sequence of the gC ORF as published by Fitzpatrick et al. (1989) . The dodecapeptides were linked to polyethylene rods and immunoscreenings were performed according to the PEPSCAN procedures described by Geysen et al. (1984) .
Results

MAbs 71 and 77 failed to react with a substantial number of BHV-1 isolates
An IPMA was performed on a panel of 237 BHV-1 isolates and the two prototype virus strains Cooper and K22, by using an anti-BHV-1 gB MAb (14), an anti-BHV-1 gC MAb (54) and two anti-BHV-1.1 MAbs (71 and 77) of as yet unidentified specificity (Table 1 ). All 239 isolates reacted in the IPMA with MAbs 14 and 54, but MAb 71 failed to react with strain K22 and with 54 of the 237 BHV-1 isolates. MAb 77 did not react Table 1 . Results of an IPMA on various BHV-1 isolates An IPMA was carried out on a panel of 237 BHV-1 isolates (found to be divisible into two groups, of 183 and 54 isolates, the second group being further divisible into groups of 38 and 16 isolates, on the basis of IPMA results), the prototype BHV-1.1 (' IBR-like ') strain Cooper, the prototype BHV-1.2 (' IPV-like ') strain K22 and a BHV-1.1 gCdeletion mutant (gCk). MAb 14 reacts with BHV-1 gB and MAb 54 reacts with BHV-1 gC. j, Positive IPMA result ; k, negative IPMA result. (Mayfield et al., 1983) .
with 16 of this group of 54 isolates and also not with strain K22. MAbs 54, 71 and 77 did react with the Dutch BHV-1.1 strain Lam, but did not react with the gC-deletion mutant constructed from this strain.
MAb 71 reacts with BHV-1.1 strains and not with BHV-1.2 strains
The 184 BHV-1 isolates that were recognized by MAb 71 included the prototype BHV-1.1 strain Cooper (Mayfield et al., 1983) and for example the BHV-1.1 strains ED1, ED3, ED4 and ED5 (Edwards et al., 1990 ) and the Dutch BHV-1.1 strain Lam (van Oirschot et al., 1995) . On the other hand, the group of 55 BHV-1 isolates that were not recognized by MAb 71 included prototype BHV-1.2 strain K22 (Mayfield et al., 1983) , 10 Australian BHV-1.2 isolates (Brake & Studdert, 1985) , BHV-1.2 strains ED2 and ED8 (Edwards et al., 1990) and the Dutch BHV-1.2 strain 61.169. This suggested that MAb 71 reacted specifically with BHV-1.1 isolates and not with BHV-1.2 isolates. To see whether such a correlation indeed existed, the MAb 71 reactivity of the isolates in our panel was compared with available information about their genotypes. The genotypes of 70 of the BHV-1 isolates in our panel were known (Mayfield et al., 1983 ; Brake & Studdert, 1985 ; (Fig. 1) . The only presently known BHV-1.1 strain that did not react with MAb 71 in an IPMA was the gC-deletion mutant constructed from the Lam strain. MAb 77 also reacted in an IPMA with all 38 BHV-1.1 strains mentioned above, but also with some of the BHV-1.2 strains.
MAbs 71 and 77 both react with a 95 kDa protein of BHV-1.1
As a first step in the identification of the antigen(s) recognized by MAbs 71 and 77, immunoblot analyses were performed on virus preparations of several BHV-1 isolates and on the Lam gC-deletion mutant. Both MAbs 71 and 77 reacted with a protein fraction with an apparent molecular mass of 95 kDa in an immunoblot analysis of protein preparations of BHV-1.1 viruses, but not with proteins of BHV-1.2 viruses or of the Lam gC-deletion mutant. As a positive control for the presence of gC in these viral protein preparations, an immunoblot analysis was also performed with anti-gC MAb 43, which reacts with a protein fraction of 95 kDa in protein preparations of both BHV-1.1 and BHV-1.2 isolates (Fig. 2) . The protein preparations of the two BHV-1.2 viruses (V155-2 and ED6) in this analysis, which reacted positively with MAb Because the above results suggested that MAbs 71 and 77 recognize gC from BHV-1.1 strains, marker-rescue experiments were performed by using DNA fragments from the gC locus of BHV-1.1 strain Lam and genomic DNA from the BHV-1.2 strain 61.169 (Fig. 3 a) . Co-transfection of the 3n3 kbp HpaIEcoRI fragment of the BHV-1.1 Lam strain, which contains the BEIA Anti-BHV-1 gC MAbs for IBR/IPV differentiation Anti-BHV-1 gC MAbs for IBR/IPV differentiation 
Baculoviruses that express BHV-1.1 gC react with MAbs 71 and 77
To confirm that MAbs 71 and 77 recognize BHV-1.1 gC, fragments of the gC gene of BHV-1.1 strain Lam were expressed in baculoviruses. To express the complete gC ORF, the 2n4 kbp BamHI-EcoRI fragment from plasmid p115 was cloned behind the polyhedrin promoter in the baculovirus genome. This BamHI-EcoRI fragment starts 60 bp upstream of the gC start codon and ends 0n7 kbp downstream of the gC stop codon. The resulting recombinant baculovirus was named p487. Sf21 cells infected with p487 reacted in the IPMA with both MAbs 71 and 77, demonstrating that MAbs 71 and 77 react with BHV-1.1 gC (Fig. 3 b) . In order to analyse the site specificity of MAbs 71 and 77 further, two more recombinant baculoviruses were constructed that expressed truncated versions of BHV-1.1 gC, p488 and p489. p488 contains the 1n1 kbp BamHI-SalI fragment that encodes the first 323 amino acids of BHV-1.1 gC and p498 contains the 0n6 kbp BamHISacI fragment that encodes the first 172 amino acids of BHV-1.1 gC ORF. Sf21 cells infected with either p488 or p489 reacted in the IPMA with MAb 71 and not with MAb 77. These results show that the antigenic determinant for MAb 71 is located within the first 172 amino acids of BHV-1.1 gC.
MAb 71 reacts with amino acids 75-80 of BHV-1.1 gC
On the basis of the conceptual translation of the gC ORF of BHV-1.1 strain Cooper (Fitzpatrick et al., 1989) , a set of 509 overlapping 12-mer oligopeptides was synthesized and used for PEPSCAN analysis (Geysen et al., 1984) . MAb 71 reacted with a set of overlapping peptides that all had amino acids (&PVGTPE)! in common (Fig. 4 a) , while MAb 77 did not react specifically (data not shown). To understand why MAb 71 failed to react with BHV-1.2 gC, the amino acid sequences of both BHV-1.1 gC (Fitzpatrick et al., 1989) and BHV-1.2 gC (Hecht et al., 1993) were compared and one amino acid difference was found within the MAb 71 epitope : residue 76 of BHV-1.1 gC is valine and residue 76 of BHV-1.2 gC is glycine. To test whether this single amino acid difference was indeed responsible for the specific reactivity of MAb 71, a PEPSCAN analysis was performed on both the BHV-1.1 and BHV-1.2 versions of this MAb 71 epitope. This analysis showed that MAb 71 did not react with the overlapping peptides that had the BHV-1.2 gC sequence (&PGGTPE)! in common (Fig. 4 b) .
Discussion
We identified two MAbs (71 and 77) that reacted with BHV-1.1 isolates but not with BHV-1.2 isolates. MAb 71 and possibly MAb 77 (in an immunoblot) can thus be used to differentiate between BHV-1.1 and BHV-1.2 strains. Metzler et al. (1985) also found a MAb (no. 12.38) that reacted with all BHV-1.1 isolates (5\13) and none of the BHV-1.2 isolates (8\13) in their panel of 13 BHV-1 strains. This MAb 12.38 recognizes uncharacterized BHV-1.1 protein VP9 and not gC (M. Engels, personal communication). Several attempts have been made to divide BHV-1 isolates into different genotypes on the basis of restriction endonuclease fragment patterns. Misra et al. (1983) proposed a division into three ' strains ' (I, II and III) and nine ' sub-strains '. Metzler et al. (1985) proposed a division into two types (1 and 2) and two subtypes (2a and 2b). More recently, Christensen et al. (1996) proposed a subdivision into six types (I-VI) and three subtypes. However, the original division into two types, BHV-1.1 and BHV-1.2 (Engels et al., 1981) , also referred to as ' Cooper-type ' and ' K22-type ' (Mayfield et al., 1983) or as ' IBR-like ' and ' IPV-like ', respectively (Ludwig, 1984 ; Pauli et al., 1984) , is the most generally accepted. The antigenic differences between BHV-1.1 and BHV-1.2 isolates found in this study and by Metzler et al. (1985) support this genotypic division.
By using marker-rescue experiments and baculovirus expression it was shown that MAbs 71 and 77 both react with BHV-1.1 gC. The epitope of MAb 71 was identified and it was shown that one amino acid difference between BHV-1.1 gC and BHV-1.2 gC was responsible for the failure of MAb 71 to react with BHV-1.2. The epitope for MAb 77 could not be Fitzpatrick et al. (1989) and Hecht et al. (1995) . Hecht et al. (1995) pointed out that the differences found at the C terminus may result from an error in the sequence of Fitzpatrick et al. (1989) . The relevant restriction enzyme sites (SacI and SalI) and the sites that react with MAbs 71 and 77 are indicated. With the exception of the heparin-binding domains, the functional domains indicated are based on Fitzpatrick et al. (1989) . The heparin-binding domains indicated are based on Okazaki et al. (1994) (O) and Liang et al. (1993) 
(L).
found with a PEPSCAN using 12-mer oligopeptides, suggesting that its epitope is formed by a larger part of gC. The gene rescue data show that the SacI fragment was sufficient to rescue the MAb 77 epitope, limiting (the differentiating residues of) the epitope of MAb 77 to the Cterminal half of gC. The amino acid differences between gC of BHV-1.1 and BHV-1.2 in this SacI fragment are limited to the central part of gC, located between the SacI and SalI sites (Fig.  5) . However, the baculovirus recombinant (BamHI-SalI) that expressed a truncated form of gC that included this central part did not react with MAb 77. This suggests that sequences downstream of the SalI site also contribute to the MAb 77 epitope. The IPMA data show that BHV-1.2 strains should be divided into two subgroups : one that reacts with MAb 77 and one that does not react with MAb 77. The strains tested from both BHV-1.2 groups, however, did not react with MAb 77 in the immunoblot analysis, showing that the MAb 77 epitope in gC of BHV-1.2 strains can differ from gC of BHV-1.1 strains in two ways : one affecting MAb 77 reactivity in the IPMA and one affecting MAb 77 reactivity in immunoblot analysis. We checked whether the subdivision of BHV-1.2 strains on the basis of their reactivity with MAb 77 in the IPMA coincided with the subdivision into 2a and 2b isolates (Metzler et al., 1985) , but we failed to find any correlation (data not shown).
The differences found in this study between gC of BHV-1.1 and BHV-1.2 may contribute to the biological differences attributed to these subtypes (Gillespie et al., 1959 ; Miller et al., 1991 ; Edwards et al., 1991) . Glycoprotein C of BHV-1 is a nonessential type I transmembrane glycoprotein that belongs to the immunoglobulin superfamily (Fitzpatrick et al., 1989) . Like the gC glycoproteins of other alphaherpesviruses, BHV-1 gC has a highly hydrophilic N-terminal region that forms long spikes on the virion and BHV-1 gC has a region that can bind heparin sulphate moieties on the surface of the host cell (Liang et al., 1993 ; Okazaki et al., 1994) . This binding plays an important role in the attachment of the virus to the host cell (reviewed by Spear, 1993) and may contribute to its cell-type tropism. Moreover, unlike other members of the gC family, BHV-1 gC has a region that is highly homologous to the constant domain of MHC class II antigens (Fitzpatrick et al., 1989) , which might have functional importance. All three gC regions mentioned above show amino acid differences between BHV-1.1 and BHV-1.2 (Fig. 5) .
The data presented in this report indicate that differences in gC may contribute to the biological differences between BHV-1.1 and BHV-1.2. This does not, however, exclude a role for other differences between BHV-1.1 and BHV-1.2, for example that identified by Metzler et al. (1995) in VP9.
